{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T01:55:03Z","timestamp":1694570103701},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00347-013-2911-1","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T05:59:26Z","timestamp":1390283966000},"page":"10-14","source":"Crossref","is-referenced-by-count":5,"title":["Vaskul\u00e4re Netzhauterkrankungen als Spiegel generalisierter Gef\u00e4\u00dfver\u00e4nderungen"],"prefix":"10.1007","volume":"111","author":[{"given":"N.","family":"Feltgen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Franko Zeitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,22]]},"reference":[{"key":"2911_CR1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00347-013-2953-4","volume":"110","author":"G\u00f6bel","year":"2013","unstructured":"G\u00f6bel W, Matlach J (2013) Hypertensive changes of the fundus. Ophthalmologe 110:995\u20131007","journal-title":"Ophthalmologe"},{"key":"2911_CR2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00347-004-1160-8","volume":"3","author":"Schnurrbusch","year":"2005","unstructured":"Schnurrbusch U, Wolf S (2005) Fundus hypertonicus. Ocular changes with systematic illnesses. Ophthalmologe 3:301\u2013312","journal-title":"Ophthalmologe"},{"key":"2911_CR3","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1056\/NEJMra032865","volume":"351","author":"Wong","year":"2004","unstructured":"Wong TY, Mitchell P (2004) Hypertensive retinopathy. N Engl J Med 351:2310\u20132317","journal-title":"N Engl J Med"},{"key":"2911_CR4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)70151-3","volume":"365","author":"Kearney","year":"2005","unstructured":"Kearney PM, Whelton M, Reynolds K et al (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217\u2013223","journal-title":"Lancet"},{"key":"2911_CR5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00347-009-2113-z","volume":"107","author":"Wolf","year":"2010","unstructured":"Wolf A, Kernt M, Kampik A, Neubauer AS (2010) Systemische kardiovaskulare Risikoabschatzung. Klassisch oder fundusbasiert? Ophthalmologe 107:814\u2013820","journal-title":"Ophthalmologe"},{"key":"2911_CR6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(07)60198-6","volume":"369","author":"Wong","year":"2007","unstructured":"Wong T, Mitchell P (2007) The eye in hypertension. Lancet 369:425\u2013435","journal-title":"Lancet"},{"key":"2911_CR7","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/HJH.0b013e328364ca4c","volume":"31","author":"Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH\/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 31:1925\u20131938","journal-title":"J Hypertens"},{"key":"2911_CR8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1055\/s-2006-941746","volume":"131","author":"Hammes","year":"2006","unstructured":"Hammes H-P, Lemmen K-D, Jochmann C, Wiedemann P (2006) Diabetic retinopathy and maculopathy. Dtsch Med Wochenschr 131:1173\u20131175","journal-title":"Dtsch Med Wochenschr"},{"key":"2911_CR9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1055\/s-0031-1273357","volume":"228","author":"Retinologische","year":"2011","unstructured":"Retinologische Gesellschaft, Deutsche Ophthalmologische Gesellschaft, Berufsverband der Augen\u00e4rzte Deutschland (2011) Recommendation of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany: treatment of diabetic maculopathy. Klin Monatsbl Augenheilkd 228:446\u2013459","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"2911_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/09286580701396720","volume":"14","author":"Klein","year":"2007","unstructured":"Klein BEK (2007) Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14:179\u2013183","journal-title":"Ophthalmic Epidemiol"},{"key":"2911_CR11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00347-010-2202-z","volume":"107","author":"Gelisken","year":"2010","unstructured":"Gelisken F, Ziemssen F (2010) Diabetic maculopathy. Diagnosis and treatment. Ophthalmologe 107:773\u2013786 (quiz 787\u2013788)","journal-title":"Ophthalmologe"},{"key":"2911_CR12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0029-1244853","volume":"135","author":"Hanefeld","year":"2010","unstructured":"Hanefeld M, Sch\u00f6nauer M, Forst T (2010) Glycemic control and cardiovascular benefit: what do we know today? Dtsch Med Wochenschr 135:301\u2013307","journal-title":"Dtsch Med Wochenschr"},{"key":"2911_CR13","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.287.19.2563","volume":"287","author":"Writing","year":"2002","unstructured":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group (2002) Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:2563\u20132569","journal-title":"JAMA"},{"key":"2911_CR14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0161-6420(81)34978-1","volume":"88","author":"Early","year":"1981","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group (1981) Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. TOphthalmology 88:583\u2013600","journal-title":"TOphthalmology"},{"key":"2911_CR15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archopht.1995.01100090070025","volume":"113","author":"Early","year":"1995","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group (1995) Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Arch Ophthalmol 113:1144\u20131155","journal-title":"Arch Ophthalmol"},{"key":"2911_CR16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.1984.01040030398010","volume":"102","author":"Klein","year":"1984","unstructured":"Klein R, Klein BE, Moss SE et al (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520\u2013526","journal-title":"Arch Ophthalmol"},{"key":"2911_CR17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archopht.1984.01040030405011","volume":"102","author":"Klein","year":"1984","unstructured":"Klein R, Klein BE, Moss SE et al (1984) The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527\u2013532","journal-title":"Arch Ophthalmol"},{"key":"2911_CR18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","volume":"317","author":"United","year":"1998","unstructured":"United Kingdom Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703\u2013713","journal-title":"BMJ"},{"key":"2911_CR19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1161\/CIRCULATIONAHA.113.002717","volume":"128","author":"Hata","year":"2013","unstructured":"Hata J, Arima H, Rothwell PM et al (2013) Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the advance trial. Circulation 128:1325\u20131334","journal-title":"Circulation"},{"key":"2911_CR20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","volume":"353","author":"Gaede","year":"1999","unstructured":"Gaede P, Vedel P, Parving HH, Pedersen O (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353:617\u2013622","journal-title":"Lancet"},{"key":"2911_CR21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(08)61411-7","volume":"372","author":"Sj\u00f8lie","year":"2008","unstructured":"Sj\u00f8lie AK, Klein R, Porta M et al (2008) Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet 372:1385\u20131393","journal-title":"Lancet"},{"key":"2911_CR22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00347-010-2223-7","volume":"107","author":"Retinologische","year":"2010","unstructured":"Retinologische Gesellschaft, Deutsche Ophthalmologische Gesellschaft, Berufsverband der Augen\u00e4rzte Deutschland (2010) Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augen\u00e4rzte Deutschlands zur Therapie des Makula\u00f6dems beim retinalen Venenverschluss. Ophthalmologe 107:583\u2013596","journal-title":"Ophthalmologe"},{"key":"2911_CR23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcjo.2012.08.017","volume":"48","author":"Khan","year":"2013","unstructured":"Khan Z, Almeida DRP, Rahim K et al (2013) 10-year Framingham risk in patients with retinal vein occlusion: a systematic review and meta-analysis. Can J Ophthalmol 48:40\u201345.e1","journal-title":"Can J Ophthalmol"},{"key":"2911_CR24","doi-asserted-by":"crossref","first-page":"e7885","DOI":"10.1136\/bmj.e7885","volume":"345","author":"Bertelsen","year":"2012","unstructured":"Bertelsen M, Linneberg A, Rosenberg T et al (2012) Comorbidity in patients with branch retinal vein occlusion: case-control study. BMJ 345:e7885","journal-title":"BMJ"},{"key":"2911_CR25","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/jth.12297","volume":"11","author":"Christiansen","year":"2013","unstructured":"Christiansen CB, Lip GY, Lamberts M et al (2013) Retinal vein and artery occlusions:a risk factor for stroke in atrial fibrillation. J Thromb Haemost 11(8):1485\u20131492","journal-title":"J Thromb Haemost"},{"key":"2911_CR26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00347-003-0845-8","volume":"100","author":"Feltgen","year":"2003","unstructured":"Feltgen N, Schmidt D, Hansen L (2003) Arterielle retinale Verschl\u00fcsse. Ophthalmologe 100:651\u2013665 (quiz 666\u2013667)","journal-title":"Ophthalmologe"},{"key":"2911_CR27","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00347-009-2112-0","volume":"107","author":"Heinz","year":"2010","unstructured":"Heinz J (2010) Internal medical investigations for non-arteritic retinal artery occlusion. Ophthalmologe 107:806\u2013813","journal-title":"Ophthalmologe"},{"key":"2911_CR28","first-page":"690","volume":"Ophthalmol","author":"Lorentzen","year":"1969","unstructured":"Lorentzen SE (1969) Occlusion of the central retinal artery. A follow-up. Acta Ophthalmol (Copenh) 47:690\u2013703","journal-title":"Acta"},{"key":"2911_CR29","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ajo.2012.03.046","volume":"154","author":"Chang","year":"2012","unstructured":"Chang YS, Jan RL, Weng SF et al (2012) Retinal artery occlusion and the 3-year risk of stroke in taiwan: a nationwide population-based study. Am J Ophthalmol 154(4):645\u2013652","journal-title":"Am J Ophthalmol"},{"key":"2911_CR30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.survophthal.2012.02.002","volume":"58","author":"Petzold","year":"2013","unstructured":"Petzold A, Islam N, Hu H-H, Plant GT (2013) Embolic and nonembolic transient monocular visual field loss: a clinicopathologic review. Surv Ophthalmol 58:42\u201362","journal-title":"Surv Ophthalmol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-013-2911-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-013-2911-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-013-2911-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:51:52Z","timestamp":1559037112000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-013-2911-1"}},"subtitle":["Was k\u00f6nnen wir voneinander lernen?"],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["2911"],"URL":"https:\/\/doi.org\/10.1007\/s00347-013-2911-1","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}